Items Tagged ‘talimogene laherparepvec’

October 28th, 2015

Imlygic® Approved for Melanoma


Imlygic® (talimogene laherparepvec), the first ever FDA-approved oncolytic virus therapy, has been approved for the treatment of melanoma. The approval is for the treatment of melanoma sites in the skin and lymph nodes that cannot be surgically removed. Imlygic is given as an injection directly into the site of cancer, and is given through a […]

View full entry

Tags: Imylgic, Melanoma, News, oncolytic virus therapy, talimogene laherparepvec